Wolfe Research analyst Justin Lake downgraded Universal Health to Peer Perform from Outperform and removed the firm’s previous $167 price target following Q4 results and FY23 guidance that came in below expectations. Several unexpected headwinds in the Acute and Corporate segments "leave more optimistic assumptions" being needed to hit the company’s target and leave less upside versus the firm’s previous views, the analyst tells investors.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on UHS:
- Universal Health downgraded to Peer Perform from Outperform at Wolfe Research
- Universal Health falls -10.5%
- UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2022 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS AND 2023 FULL YEAR EARNINGS GUIDANCE
- Universal Health sees FY23 adjusted EPS of $9.50-$10.50, consensus $10.79
- Universal Health reports Q4 adjusted EPS $3.02, consensus $2.96
